Overview

Lipografting Versus Steroid Injections for Treatment of Carpal Tunnel Syndrome

Status:
Unknown status
Trial end date:
2019-12-01
Target enrollment:
Participant gender:
Summary
This study applies the regenerative properties of autologous fat transfer to treat mild to moderate carpal tunnel syndrome in comparison to the current standard of care, corticosteroid treatment. The investigators hypothesize the fat transfer would prevent scar formation and aid in nerve excursion along the canal (while the neoangiogenic and regenerative growth factors could stimulate nerve regeneration) better than the standard of care treatment.
Phase:
Early Phase 1
Details
Lead Sponsor:
Columbia University
Collaborator:
Orthopaedic Scientific Research Foundation
Treatments:
Cortisone